rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1997-1-8
|
pubmed:abstractText |
The usefulness of posatirelin (L-pyro-2-aminoadipyl-L-leucyl-L-prolinamide), a synthetic peptide having modulatory activity on the monoaminergic and cholinergic systems and neurotrophic effects, was evaluated in vascular dementia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0001-6314
|
pubmed:author |
pubmed-author:AgliatiGG,
pubmed-author:AmbrosoliLL,
pubmed-author:CaratozzoloPP,
pubmed-author:FossatiLL,
pubmed-author:FrattolaLL,
pubmed-author:GirardelloRR,
pubmed-author:MartucciNN,
pubmed-author:MurriLL,
pubmed-author:NappiGG,
pubmed-author:ParnettiLL,
pubmed-author:PoliAA,
pubmed-author:PucaF MFM,
pubmed-author:SeninUU
|
pubmed:issnType |
Print
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
456-63
|
pubmed:dateRevised |
2006-8-16
|
pubmed:meshHeading |
|
pubmed:year |
1996
|
pubmed:articleTitle |
Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placebo.
|
pubmed:affiliation |
Perugia University, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|